Abstract
Background and Objectives Vision impairment (VI), hearing impairment (HI), and dual sensory impairment (DSI), are prevalent among older adults and have been associated with cognitive impairment in later life. Knowledge about mediating pathways that account for the association between sensory impairment and cognitive impairment is scarce. Mediators of this association could serve as possible future intervention targets. We examined longitudinal associations between sensory impairment and cognitive functioning indirectly through social isolation.
Research Design and Methods Data were taken from a nationally representative panel study, The National Health and Aging Trends Study, an annual survey of Medicare beneficiaries age ≥ 65. Participants (N = 6,286) from Rounds 5, 6, and 7 (2015, 2016, 2017), with complete data on self-reported VI and/or HI status at baseline. Structural equation models were estimated to test longitudinal direct and indirect associations.
Results Adjusting for covariates, cross-sectional results indicated that all sensory impairments (VI, HI, and DSI) were negatively associated with all cognitive functioning measures through social isolation. Longitudinally, only VI was indirectly associated with word-recall scores across 1 and 2 years through social isolation, as well as across 2 years for orientation.
Discussion and Implications As social isolation is both a consequence of sensory impairment and a risk factor for cognitive impairment, it provided a starting point from which to study the process of cognitive decline among those with sensory impairments. Awareness of the association of sensory impairment with social isolation, as well as its longitudinal implications for cognitive health, may enhance our ability to intervene.
Competing Interest Statement
Dr. Ehrlich reports grants from National Institutes of Health, during the conduct of the study. All other authors declare no competing interests.
Funding Statement
This work was supported by the National Institutes of Health [grant number K23EY027848 to JRE]; and unrestricted grants from Research to Prevent Blindness, New York, NY, to the Department of Ophthalmology & Visual Sciences, University of Utah and University of Michigan.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRB office of the first author deemed the research exempt as human subjects data are publicly available and de-identified.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
corinna_tanner{at}byu.edu
richa34{at}byu.edu
melanie.serrao{at}gmail.com
brian.stagg{at}hsc.utah.edu
markus.wettstein{at}dza.de
joshre{at}umich.edu
